These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10089859)

  • 1. Combining nonpharmacologic therapies for advanced heart failure: the Münster experience with the assist device-defibrillator combination.
    Deng MC; Tjan TD; Asfour B; Gradaus R; Böcker D; Loick HM; Baba HA; Breithardt G; Scheld HH; Borggrefe M; Hammel D
    Am J Cardiol; 1999 Mar; 83(5B):158D-160D. PubMed ID: 10089859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy?
    Schmidinger H
    Am J Cardiol; 1999 Mar; 83(5B):151D-157D. PubMed ID: 10089858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
    Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation.
    Da Rosa MR; Sapp JL; Howlett JG; Falkenham A; Légaré JF
    J Heart Lung Transplant; 2007 Dec; 26(12):1336-9. PubMed ID: 18096488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridge to Transplantation With Long-Term Mechanical Assist Devices in Adults With Transposition of the Great Arteries.
    Michel E; Orozco Hernandez E; Enter D; Monge M; Nakano J; Rich J; Anderson A; Backer C; McCarthy P; Pham D
    Artif Organs; 2019 Jan; 43(1):90-96. PubMed ID: 30129258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device in a patient with a concomitant subcutaneous implantable cardioverter defibrillator.
    Saeed D; Albert A; Westenfeld R; Maxhera B; Gramsch-Zabel H; O'Connor S; Lichtenberg A; Winter J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):e32-3. PubMed ID: 23778251
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.
    Gandjbakhch E; Rovani M; Varnous S; Maupain C; Chastre T; Waintraub X; Pousset F; Lebreton G; Duthoit G; Badenco N; Himbert C; Leprince P; Hidden-Lucet F
    Arch Cardiovasc Dis; 2016; 109(8-9):476-85. PubMed ID: 27344378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
    Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M; Wan C; Singh V; Salehi N; Ahmad J; Szymkiewicz SJ; Thakur RK
    J Heart Lung Transplant; 2015 Oct; 34(10):1305-9. PubMed ID: 26094085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of ventricular assist device as bridge to simultaneous heart and kidney transplantation in patients with cardiac and renal failure.
    Yanagida R; Czer LS; Ruzza A; Schwarz ER; Simsir SA; Jordan SC; Trento A
    Transplant Proc; 2013; 45(6):2378-83. PubMed ID: 23953551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis.
    Clerkin KJ; Topkara VK; Mancini DM; Yuzefpolskaya M; Demmer RT; Dizon JM; Takeda K; Takayama H; Naka Y; Colombo PC; Garan AR
    J Heart Lung Transplant; 2017 Jun; 36(6):633-639. PubMed ID: 28089072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices.
    Lee W; Tay A; Subbiah RN; Walker BD; Kuchar DL; Muthiah K; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Spratt P; Jansz PC; Granger E; Dhital K; Hayward CS
    Pacing Clin Electrophysiol; 2015 Aug; 38(8):925-33. PubMed ID: 25940215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioverter defibrillator therapy as a bridge to heart transplantation.
    Trappe HJ; Wenzlaff P
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 2):622-31. PubMed ID: 7777427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.
    Younes A; Al-Kindi SG; Alajaji W; Mackall JA; Oliveira GH
    Int J Cardiol; 2017 Mar; 231():211-215. PubMed ID: 28043679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator and wait-list outcomes in pediatric patients awaiting heart transplantation.
    El-Assaad I; Al-Kindi SG; Oliveira GH; Boyle GJ; Aziz PF
    Heart Rhythm; 2015 Dec; 12(12):2443-8. PubMed ID: 26247317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.